ENVESTNET ASSET MANAGEMENT INC - UTAH MED PRODS INC ownership

UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 68 filers reported holding UTAH MED PRODS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ENVESTNET ASSET MANAGEMENT INC ownership history of UTAH MED PRODS INC
ValueSharesWeighting
Q3 2023$339,713
-5.7%
3,950
+2.2%
0.00%
Q2 2023$360,225
+4.0%
3,865
+5.8%
0.00%
Q1 2023$346,297
-4.4%
3,654
+1.4%
0.00%
Q4 2022$362,210
+18.8%
3,603
+0.7%
0.00%
Q3 2022$305,000
-1.0%
3,579
-0.3%
0.00%
Q2 2022$308,000
+34.5%
3,590
+40.8%
0.00%
Q1 2022$229,000
-10.2%
2,5500.0%0.00%
Q4 2021$255,000
+4.9%
2,550
-2.4%
0.00%
Q3 2021$243,000
+9.5%
2,6140.0%0.00%
Q2 2021$222,000
+0.5%
2,614
+2.5%
0.00%
Q1 2021$221,0002,5500.00%
Other shareholders
UTAH MED PRODS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HealthInvest Partners AB 40,000$4,000,0005.64%
Clean Yield Group 14,474$1,447,0000.46%
RICE HALL JAMES & ASSOCIATES, LLC 113,833$11,383,0000.40%
Ranger Investment Management 68,730$6,873,0000.38%
ISTHMUS PARTNERS, LLC 17,534$1,753,0000.29%
Cardinal Capital Management 10,097$1,010,0000.20%
GLOBEFLEX CAPITAL L P 19,420$1,942,0000.20%
Ancora Advisors LLC 26,689$2,669,0000.06%
Penobscot Investment Management Company, Inc. 4,000$400,0000.05%
SEIZERT CAPITAL PARTNERS, LLC 10,430$1,043,0000.05%
View complete list of UTAH MED PRODS INC shareholders